Ranbaxy Laboratories Ltd. (Solus) Generic : Levetiracetam
₹ 189.00 500mg 10 Tablets
PO/IV- Adjunct in partial seizures- Initial: 500 mg twice daily on the 1st day, may increase gradually. Max: 3 g/day.
Monotherapy for partial seizures with or without secondary generalization- Initial: 500 mg/day, may increase gradually. Max: 3 g/day.
Central Nervous System:
Drowsiness, weakness, headache, hostility, fatigue, nervousness, dizziness, personality disorder, irritability, agitation, emotional lability, depression, mood swings, vertigo, anxiety, unsteadiness, seizures, memory loss, confusion, increased reflexes, tingling, aggression and suicidal behavior.
Skin: Itching, skin discoloration, rash and loss of hair.
Eye and ENT: Inflammation of nasopharynx, stuffy nose, inflammation of conjunctiva, blurred vision, double vision and ear pain.
Gastrointestinal: Vomiting, loss of appetite, diarrhea, nausea, gastroenteritis, constipation and inflammation of pancreas.
Genitourinary: Albumin in urine and urine abnormality.
Blood: Easy bruising, deficiency of all three blood cell types (with bone marrow suppression in some cases).
Liver: Abnormal LFTs (liver function test), liver failure and inflammation.
Metabolic: Dehydration and weight loss.
Musculoskeletal: Neck pain.
Respiratory: Increased cough, asthma and sinusitis.
Miscellaneous:Accidental injury, infection, influenza, pain, flu syndrome, face edema and viral infection.
May be taken with or without food. (Oral solution should be diluted in a glass of water.) Administer IV levetiracetam as 15-min infusion following dilution in 100 ml of a compatible diluent.
Do not change the dosage.
Intravenous: Once reconstituted store at 15-30°C and use within 24 hr. Store tablets, oral solution, and undiluted IV injection at 15-30°C.